உயிர் மருத்துவ ஆராய்ச்சி சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உயிர் மருத்துவ ஆராய்ச்சி சேவைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உயிர் மருத்துவ ஆராய்ச்சி சேவைகள் Today - Breaking & Trending Today

Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, .
Skye Bioscience, Inc.March 8, 2021 GMT
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today the appointment of scientific innovators and cannabinoid experts, Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to its scientific advisory board.
“We are honored to welcome two of the world’s most influential thought leaders in cannabinoid science, Drs. Appendino and Muñoz, to our scientific advisory board as we continue to advance our research and deepen our understanding of cannabinoid-based medicines,” said Punit Dhil ....

San Diego , United States , Skye Bioscience , Karam Takhar , Robert Ritch , Louis Pasquale , Punit Dhillon , Acta Pharmaceutica Sinica , Jeffrey Goldberg , Giovanni Appendino , Natural Products Research , Italian Academy Of Sciences , University Of Eastern Piedmont , Department Of Pharmaceutical Sciences , Innohealth Group , Evonik Industries Gmb , Institute Maimonides For Biomedical Research , Department Of Cell Biology , Skye Bioscience Inc , Glaucoma Services , Corporate Development Investor Relations , Translational Ophthalmology Research , Exchange Commission , Department Of Ophthalmology , Immunology Of The University , Icahn School Of Medicine ,

Mydecine Innovations Group Files Final Prospectus in Connection with Bought Deal Offering of Units


Press release content from Business Wire. The AP news staff was not involved in its creation.
Mydecine Innovations Group Files Final Prospectus in Connection with Bought Deal Offering of Units
February 9, 2021 GMT
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“
Mydecine ” or the “
Company’ ), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, is pleased to announce that, in connection with its bought deal offering (the “
Offering ”) previously announced on January 14, 2021, it has filed its final short form prospectus (the “
Prospectus ”) with the securities commissions or similar authorities in each province of Canada, other than Quebéc. ....

United States , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Company The Units , Mydecine Innovations Group Inc , Canaccord Genuity Corp , Companya Common Share , Strategic Communications , Mydecine Innovations Group , Health Canada , Canadian Securities Exchange , Mydecine Innovations Group Media , Corp Communications , Innovations Group , Canaccord Genuity , Common Share , Each Warrant , Closing Date , Issue Price , Over Allotment Option , Common Shares , Warrant Shares , United States Securities Act , Chief Executive , Business Wire ,

Active Motif Partners with Arima Genomics to Launch End-to-End Hi-C Service


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Active Motif Partners with Arima Genomics to Launch End-to-End Hi-C Service
February 9, 2021 GMT
SAN DIEGO and CARLSBAD, Calif., Feb. 9, 2021 /PRNewswire/ Epigenetics-based research tools and services company, Active Motif, Inc., announced today that it has launched an end-to-end Hi-C service in partnership with Arima Genomics, Inc. to investigate the three-dimensional folding patterns of the genome, providing researchers with greater access to this powerful technology and advancing their research.
The launch of this Hi-C service extends Active Motif’s 15 years of experience and expertise offering Epigenetic Services, such as ChIP-Seq and ATAC-Seq services, and now allows researchers to gain a deeper understanding of the biological mechanisms at play in their clinical samples or experimental systems. Active Motif continues to offer the most comprehensive offering of epig ....

United States , San Diego , Wellcome Sanger Insitute , Kevin Bryant , Siddarth Selvaraj , Fritz Eibel , Epigenetic Services , Motif Inc , Motif Epigenetic Service , Arima Genomics Inc , Active Motif , Arima Genomics , Active Motif Epigenetic Service , Chief Commercial Officer , Corporate News , North America , Health Care Industry , Pr Newswire , Genetics Research , Products And Services , New Products And Services , Biomedical Research Services , Medical Research , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , வெல்கம் சாங்கர் கல்வி ,

PureTech Adds Bharatt Chowrira, PureTech's President and Chief of Business and Strategy, to Board of Directors


Press release content from Business Wire. The AP news staff was not involved in its creation.
PureTech Adds Bharatt Chowrira, PureTech’s President and Chief of Business and Strategy, to Board of Directors
January 29, 2021 GMT
PureTech announced the appointment of Bharatt Chowrira, Ph.D., J.D., to its Board of Directors. Dr. Chowrira has served as PureTech’s President and Chief of Business and Strategy since March 2017. (Photo: Business Wire)
PureTech announced the appointment of Bharatt Chowrira, Ph.D., J.D., to its Board of Directors. Dr. Chowrira has served as PureTech’s President and Chief of Business and Strategy since March 2017. (Photo: Business Wire) ....

United States , United Kingdom , Gurnet Point , Bennett Shapiro , Ben Shapiro , Allison Mead Talbot , Bharatt Chowrira , Paulc Cabot , Stephenm Muniz , Bob Langer , Stephanie Simon , Dame Marjorie Scardino , Kiran Mazumdar Shaw , Chris Viehbacher , Stephen Muniz , John Lamattina , Daphne Zohar , H Robert Horvitz , Dennis Ausiello , Raju Kucherlapati , Macarthur Foundation , Karuna Therapeutics Inc , Idun Pharmaceuticals , Pfizer Global Research , Board Of Directors Vedanta Biosciences Inc , Continuous Health ,